Print this page
Major events of 2008
Objectives were largely achieved
Operating result rose by 16%
Pharmaceuticals increased contribution
Financial indicators remain very solid
Three new approvals for Erbitux
Strengthened biotech research
Slowdown hits Liquid Crystals
Solid balance sheet
Good development of net equity
Total revenues
Operating result
Free cash flow
by business sector
€ million
by business sector
€ million
Free cash flow and underlying free cash flow
€ million
made by Nexxar - your next annual report online!, Vienna - Austria
